Growth differentiation factor 15 in heart failure: an update (Q38041973)

27 August 2017

title

Growth differentiation factor 15 in heart failure: an update (English)

1 reference

27 August 2017

0 references

Kai C Wollert

1

1 reference

27 August 2017

Tibor Kempf

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current heart failure reports

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

337-345

1 reference

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Aging-associated cardiovascular changes and their relationship to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Diabetes and the risk of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Anemia and chronic heart failure implications and treatment options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Exercise limitation in chronic heart failure: central role of the periphery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Emerging biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth-differentiation factor-15 in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Latent TGF-β structure and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

A gene atlas of the mouse and human protein-encoding transcriptomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Desmoglein 2 mutant mice develop cardiac fibrosis and dilation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Cardiac myocyte gene expression profiling during H2O2-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Gene expression pattern in biomechanically stretched cardiomyocytes: evidence for a stretch-specific gene program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

B-type natriuretic peptide in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Influence of postprandial triglyceride-rich lipoproteins on lipid-mediated gene expression in smooth muscle cells of the human coronary artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

GDF-15 is abundantly expressed in plexiform lesions in patients with pulmonary arterial hypertension and affects proliferation and apoptosis of pulmonary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Identification of macrophage inhibitory cytokine-1 in adipose tissue and its secretion as an adipokine by human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Circulating concentrations of growth-differentiation factor 15 in apparently healthy elderly individuals and patients with chronic heart failure as assessed by a new immunoradiometric sandwich assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The role of mRNA decay in p53-induced gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Profile of gene expression regulated by induced p53: connection to the TGF-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

A p53-type response element in the GDF15 promoter confers high specificity for p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The p53 network: cellular and systemic DNA damage responses in aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Telomeres and mitochondria in the aging heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Telomere dysfunction induces metabolic and mitochondrial compromise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth Differentiation Factor 15 for Risk Stratification and Selection of an Invasive Treatment Strategy in Non ST-Elevation Acute Coronary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Serial analyses of N-terminal pro-B-type natriuretic peptide in patients with non-ST-segment elevation acute coronary syndromes: a Fragmin and fast Revascularisation during In Stability in Coronary artery disease (FRISC)-II substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Use of natriuretic peptides to guide and monitor heart failure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Reference change values and determinants of variability of NT-proANP and GDF15 in stable chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Variability of N-terminal probrain natriuretic peptide in stable chronic heart failure and its relation to changes in clinical variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Use of a continuous-flow device in patients awaiting heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Effects of Continuous-Flow Versus Pulsatile-Flow Left Ventricular Assist Devices on Myocardial Unloading and Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Is oxidative stress a therapeutic target in cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The haplotype of the growth-differentiation factor 15 gene is associated with left ventricular hypertrophy in human essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

The Relationship between Insulin Resistance and the Cardiovascular Biomarker Growth Differentiation Factor-15 in Obese Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11897-012-0113-9

Growth Differentiation Factor-15: Induction in Liver Injury Through p53 and Tumor Necrosis Factor-Independent Mechanisms1

21 January 2018

1 reference

12 December 2020

Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study

1 reference

12 December 2020

Tailored therapy for heart failure: the role of biomarkers

1 reference

12 December 2020

Connecting obesity, aging and diabetes

1 reference

12 December 2020

Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction

1 reference

12 December 2020

Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury

1 reference

12 December 2020

Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome

1 reference

12 December 2020

The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy

1 reference

12 December 2020

A crucial role for adipose tissue p53 in the regulation of insulin resistance

1 reference

12 December 2020

Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22

1 reference

12 December 2020

Growth differentiation factor 15 acts anti-apoptotic and pro-hypertrophic in adult cardiomyocytes

1 reference

12 December 2020

Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation

1 reference

12 December 2020

10.1007/S11897-012-0113-9

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1029340778

0 references

Fatcat ID

release_ynf66nwcjjbzjk7amz7wbazyle

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ynf66nwcjjbzjk7amz7wbazyle

24 November 2022

mapped directly with Wikidata item

1 reference